Results 21 to 30 of about 3,694,568 (218)
Valve-Related Outcomes up to Six Years of a Next-Generation Bovine Pericardial Bioprosthesis Compared with Its Predecessor: A Propensity-Matched Analysis [PDF]
Medical SciencesBackground: Current ESC/EACTS guidelines recommend bioprosthetic valves for aortic valve replacement (AVR) in patients > 65 years, yet their use is increasing among younger individuals.
Alessandra Francica +4 more
doaj +2 more sources
Archives of Cardiovascular Diseases, 2022 BACKGROUND Transcatheter aortic valve replacement is an established treatment for high- or intermediate-risk patients with symptomatic aortic valve stenosis.
M. Erlebach +8 more
semanticscholar +3 more sources
Journal of Cardiac Surgery, 2021 To determine the outcomes of bioprosthetic valve fracture (BVF) in valve‐in‐valve transcatheter aortic valve implantation (ViV‐TAVI) for patients with structural valve degeneration (SVD) of bioprosthetic surgical valves (BSV) implanted during surgical ...
M. Sá +10 more
semanticscholar +3 more sources
Polymorphic Size of Lipoprotein(a) and Structural Bioprosthetic Valve Degeneration.
Archives of Cardiovascular DiseasesThe use of biological heart valves (BHV) is constantly growing for the treatment of patients with aortic stenosis and their durability arises as a main concern in the field.
R. Capoulade +19 more
semanticscholar +6 more sources
European Heart Journal Supplements, 2023 Biological prostheses are increasingly been used in young patients to avoid anticoagulation. The Edwards Inspiris aortic bioprosthesis is extremely promising in this population, since it has shown reduced calcification of the prosthetic leaflets in
I. Paduvakis +3 more
semanticscholar +2 more sources
Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch? [PDF]
Journal of Thoracic Disease, 2018 We reported two cases of early structural valve degeneration (SVD) with Mitroflow prosthesis in aortic position in patients above the age of 65 years. Microscopic aspects have been analysed to investigate the intrinsic mechanism of SVD. New techniques to improve the structure and the preservation of this prosthesis are needed in order to reduce ...
Ruvolo G. +9 more
openaire +6 more sources
Open Journal of Anesthesiology, 2014 Heart valve replacement is a common cardiac surgical procedure used to treat native valvular diseases such as aortic and mitral stenosis and regurgitation. These procedures reduce the morbidity and mortality associated with diseased native valves and yet come at the expense of prosthetic valve complications.
Carolyn J. Mehaffey, David Asher Cantor
exaly +3 more sources
New Insights Into the Pathophysiology of Structural Bioprosthetic Valve Degeneration
Journal of the Heart Valve SocietyBiological heart valves (BHVs) are currently the main prosthetic substitute used to treat patients with severe valvular heart diseases. Unlike mechanical valves, BHVs provide better hemodynamic profile and lower thrombogenicity. However, their durability
M. Sallé +13 more
semanticscholar +2 more sources
Long-term Transcatheter Aortic Valve Durability [PDF]
Interventional Cardiology: Reviews, Research, Resources, 2019 Transcatheter aortic valve implantation (TAVI) has become the standard of care for high-risk and inoperable surgical patients and a valid alternative to surgery for low- and intermediate-risk patients with severe, symptomatic aortic stenosis.
Giuliano Costa +4 more
doaj +2 more sources
P3697A reappraisal of bioprosthetic aortic valve failure related to structural valve degeneration
European Heart Journal, 2019 Structural valve degeneration (SVD) remains a major complication of aortic bioprostheses. We aimed to assess the mode of SVD leading to bioprosthetic aortic valve failure (BVF) in a large series of patients.
T. Letourneau +10 more
semanticscholar +2 more sources